Altimmune (ALT1) Ownership - Who Owns Altimmune?
0 Followers
Altimmune (ALT1) Ownership Overview
- 0.42% Insiders
- 12.31% Mutual Funds
- 0.99% Other Institutional Investors
- 14.02% ETFs
- 72.26% Public Companies and Individual Investors
The ownership structure of Altimmune (MX:ALT1) stock is a mix of institutional, retail, and individual investors. Approximately 27.32% of the company’s stock is owned by Institutional Investors, 0.42% is owned by Insiders, and 72.26% is owned by Public Companies and Individual Investors.
The ownership structure of Altimmune (MX:ALT1) stock is a mix of institutional, retail, and individual investors. Approximately 27.32% of the company’s stock is owned by Institutional Investors, 0.42% is owned by Insiders, and 72.26% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 12, 2026 | Jerome Benedict Durso | $44,250 | |
| Apr 05, 2026 | John Gill | $31,280 | |
| Mar 31, 2026 | Jerome Benedict Durso | $47,100 | |
| Mar 31, 2026 | Gregory Weaver | $31,400 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 20,385,284 | Institution | 10.48% | 46,335,751 |
| Vanguard | 9,407,442 | Institution | 4.84% | 21,383,116 |
| Ishares | 9,388,767 | Institution | 4.83% | 21,340,667 |
| Vanguard Index Funds | 7,984,988 | Institution | 4.11% | 18,149,878 |
| Andreas Halvorsen | 6,700,000 | Institution | 3.44% | 15,229,100 |
| Peter Kolchinsky | 6,500,000 | Institution | 3.34% | 14,774,500 |
| Spdr | 5,370,293 | Institution | 2.76% | 12,206,676 |
| Michael Rockefeller | 3,400,312 | Institution | 1.75% | 7,728,909 |
| Vanguard Horizon Funds | 3,386,812 | Institution | 1.74% | 7,698,224 |
| Fidelity Salem Street Trust | 2,481,413 | Institution | 1.28% | 5,640,252 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 7,984,988 | Institution | 4.11% | 18,149,878 |
| Vanguard Horizon Funds | 3,386,812 | Institution | 1.74% | 7,698,224 |
| Fidelity Salem Street Trust | 2,481,413 | Institution | 1.28% | 5,640,252 |
| Fidelity Concord Street Trust | 1,899,683 | Institution | 0.98% | 4,317,979 |
| Blackrock Funds | 1,592,068 | Institution | 0.82% | 3,618,771 |
| Vanguard Scottsdale Funds | 1,344,747 | Institution | 0.69% | 3,056,610 |
| Vanguard Explorer Fund | 1,213,513 | Institution | 0.62% | 2,758,315 |
| Fidelity Rutland Square Trust Ii | 663,391 | Institution | 0.34% | 1,507,888 |
| Schwab Capital Trust | 624,378 | Institution | 0.32% | 1,419,211 |
| Vanguard World Fund | 576,186 | Institution | 0.30% | 1,309,671 |
FAQ
Who Owns Altimmune (MX:ALT1)?
According to the latest TipRanks data, approximately 27.32% of the company's stock is held by institutional investors, 0.42% is held by insiders, and 72.26% is held by public companies and individual investors.
What percentage of Altimmune (MX:ALT1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.32% of Altimmune (MX:ALT1) stock is held by institutional investors: 12.31% by mutual funds, 14.02% by ETFs and 0.99% by other institutional investors.
What percentage of Altimmune (MX:ALT1) stock is held by retail investors?
According to the latest TipRanks data, approximately 72.26% of Altimmune (MX:ALT1) stock is held by public companies and individual investors.
Who owns the most shares of Altimmune (MX:ALT1)?
BlackRock, Inc. owns the most shares of Altimmune (MX:ALT1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
